Get the newest information about «Health Technology Assessments (HTA)»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

As soon as new content is published
Daily
Weekly

You will only receive an alert if new information was published since you received one.

[Missing text '/shared/subscription/emailadress' for 'English']

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

Health Technology Assessments (HTA)

Health Technology Assessments (HTA)

The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.

Les på norsk

HTA for low and middle-income countries

Article

Supporting implementation of HTA in low-and middle-income countries

The Norwegian Institute of Public Health (NIPH) is partnering with low-and middle-income countries to support local implementation of health technology assessments (HTA).

Updated 14.04.2021

Article

Vaccine communication and digital strategies

Governments worldwide are currently planning the rollout of COVID-19 vaccines. Here are three information leaflets for planners and implementers.

Published 21.12.2020

Article

HTA status in the Balkan region

A WHO workshop on HTA in support of universal health coverage in the Balkan region was held in Ljubljana, Slovenia, in February 2020.

Published 23.11.2020

Reports

Health technology assessment

Intravenous immunoglobulin treatment in children with PANS/PANDAS conditions

We have investigated the effect and safety of treatment with immunoglobulins in the conditions PANS) and PANDAS.

Published 09.03.2021

Health technology assessment

Evaluation of tests for FLT3 mutations in acute myeloid leukaemia (AML)

Norwegian Institute of Public Health has assessed tests for FLT3 mutations in the treatment of acute myeloid leukemia (AML).

Published 01.03.2021

Health technology assessment

Subacromial decompression surgery for impingement syndrome

We have conducted a rapid HTA of subacromial decompression surgery for impingement syndrome on behalf of the Commis-sioning Forum Regional Health Authority (RHA).

Published 01.03.2021

Health technology assessment

Hydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapy

We were commissioned to perform a health technology assessment of SpaceOAR™ hydrogel for prevention of radiation-induced side effects following treatment for prostate cancer.

Published 10.02.2021

Health technology assessment

Hyperbaric oxygen therapy for radiation-induced cystitis

The evidence base for effects of hyperbaric oxy-gen treatment consists of two, small randomised controlled trials.

Published 13.11.2020

Health technology assessment

Intracoronary lithotripsy for the treatment of coronary artery disease

We were commissioned to conduct a health technology assessment (HTA) on intracoronary lithotripsy for the treatment of patients with coronary artery disease.

Published 28.09.2020

Health technology assessment

Abdominal aorta aneurysm (AAA) screening of men aged 65

In this HTA we have assessed the clinical effectiveness of screening all 65-years old men for AAA in Norway by updating an earlier HTA report from the Norwegian Institute of Public Health.

Published 25.06.2020

Health technology assessment

Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment

The objective for this health technology assessment was to evaluate clinical efficacy and cost effectiveness for disease-modifying drugs for the treatment of primary progressive multiple sclerosis.

Published 18.02.2020

Health technology assessment

Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment

We were asked to conduct a HTA on "Organ donation using normothermic regional perfusion (NRP) in patients who die of cardiac and respiratory arrest when life-sustaining treatment is withdrawn".

Published 17.12.2019

Projects

Disinvestment of medical technologies in Specialist Healthcare Services
Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
Intermittent pneumatic compression to prevent deep vein thrombosis (DVT) in immobile patients with acute stroke
Surgery for carpal tunnel syndrome - Protocol for Health Technology Assessment

See all

Health Technology Assessments (HTA)

HTA for low and middle-income countries

Supporting implementation of HTA in low-and middle-income countries

Vaccine communication and digital strategies

HTA status in the Balkan region

Reports

Intravenous immunoglobulin treatment in children with PANS/PANDAS conditions

Evaluation of tests for FLT3 mutations in acute myeloid leukaemia (AML)

Subacromial decompression surgery for impingement syndrome

Hydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapy

Hyperbaric oxygen therapy for radiation-induced cystitis

Intracoronary lithotripsy for the treatment of coronary artery disease

Abdominal aorta aneurysm (AAA) screening of men aged 65

Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment

Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment

Projects

See also

Systematic reviews

Health service quality measurements

Evidence to Decisions